These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29414387)

  • 101. A brief overview of methamphetamine use treatment in Iran: Intervention and practice.
    Mehrjerdi ZA
    J Res Med Sci; 2013 Dec; 18(12):1018-20. PubMed ID: 24523790
    [No Abstract]   [Full Text] [Related]  

  • 102. Methamphetamine intoxication in emergency departments of hospitals in iran: implications for treatment.
    Alam Mehrjerdi Z; Noroozi A
    Iran J Med Sci; 2013 Dec; 38(4):347-8. PubMed ID: 24293791
    [No Abstract]   [Full Text] [Related]  

  • 103. History dependence of a two-level system.
    Huang M; Sethna JP
    Phys Rev B Condens Matter; 1991 Feb; 43(4):3245-3254. PubMed ID: 9997633
    [No Abstract]   [Full Text] [Related]  

  • 104. Investigating Cognitive Functions in Methadone Users in Comparison with Methadone and Methamphetamine Users and Control Group.
    Eslami-Shahrbabaki M; Barfehee D; Parvaresh N; Zamani E; Soltaninejad A; Ahmadi A
    Addict Health; 2022 Jan; 14(1):1-6. PubMed ID: 35573763
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Psychosocial Interventions for Amphetamine Type Stimulant Use Disorder: An Overview of Systematic Reviews.
    Tran MTN; Luong QH; Le Minh G; Dunne MP; Baker P
    Front Psychiatry; 2021; 12():512076. PubMed ID: 34220557
    [No Abstract]   [Full Text] [Related]  

  • 106. Healthcare Contacts Regarding Circulatory Conditions among Swedish Patients in Opioid Substitution Treatment, with and without On-Site Primary Healthcare.
    Bäckström E; Troberg K; Håkansson A; Dahlman D
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33925318
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Association of PICK1 and BDNF variations with increased risk of methamphetamine dependence among Iranian population: a case-control study.
    Tajbakhsh A; Alimardani M; Asghari M; Abedini S; Saghafi Khadem S; Nesaei Bajestani A; Alipoor F; Alidoust M; Savardashtaki A; Hashemian P; Pasdar A
    BMC Med Genomics; 2021 Jan; 14(1):27. PubMed ID: 33499851
    [TBL] [Abstract][Full Text] [Related]  

  • 108. The therapeutic effects of methylphenidate and matrix-methylphenidate on addiction severity, craving, relapse and mental health in the methamphetamine use disorder.
    Aryan N; Banafshe HR; Farnia V; Shakeri J; Alikhani M; Rahimi H; Sehat M; Mamsharifi P; Ghaderi A; Omidi A
    Subst Abuse Treat Prev Policy; 2020 Sep; 15(1):72. PubMed ID: 32977820
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Technology and innovation in the psychosocial treatment of methamphetamine use, risk and dependence.
    Kay-Lambkin FJ
    Drug Alcohol Rev; 2008 May; 27(3):318-25. PubMed ID: 18368614
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Methamphetamine dependence in methadone treatment services in Iran: the first literature review of a new health concern.
    Alammehrjerdi Z; Ezard N; Dolan K
    Asian J Psychiatr; 2018 Jan; 31():49-55. PubMed ID: 29414387
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Methamphetamine use and methadone maintenance treatment: an emerging problem in the drug addiction treatment network in Iran.
    Shariatirad S; Maarefvand M; Ekhtiari H
    Int J Drug Policy; 2013 Nov; 24(6):e115-6. PubMed ID: 23773684
    [No Abstract]   [Full Text] [Related]  

  • 112. Methamphetamine use and treatment in Iran: A systematic review from the most populated Persian Gulf country.
    Alam-mehrjerdi Z; Mokri A; Dolan K
    Asian J Psychiatr; 2015 Aug; 16():17-25. PubMed ID: 26123235
    [TBL] [Abstract][Full Text] [Related]  

  • 113. The Persian methamphetamine use in methadone treatment in Iran: implication for prevention and treatment in an upper-middle income country.
    Alam-Mehrjerdi Z; Abdollahi M
    Daru; 2015 Nov; 23():51. PubMed ID: 26578071
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial.
    Ahmadi J; Razeghian Jahromi L
    Trials; 2017 Jun; 18(1):259. PubMed ID: 28587620
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Oxytocin-enhanced motivational interviewing group therapy for methamphetamine use disorder in men who have sex with men: study protocol for a randomized controlled trial.
    Stauffer CS; Moschetto JM; McKernan SM; Hsiang E; Borsari B; Woolley JD
    Trials; 2019 Feb; 20(1):145. PubMed ID: 30791944
    [TBL] [Abstract][Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.